Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > For those of you

<< Previous

Bullboard Posts

Next >>

Comment by FGPstockon Oct 04, 2023 6:33pm

179 Views

Post# 35669977

RE:RE:RE:RE:RE:RE:For those of you

wild1, if big pharma knew the potential of this technology, why would have someone bought into the company. This is something I struggle w. Seems like the only ones who believe in the technology are us retail investors. Research capital only has an .80 target and they have to like is because they raise 95% of the funds for Tlt. Most of us feel this technology should get 10,20,50+ dollars. We have a hard time raising money when the potential could b more than any other investment. I have been thinkin this for 7+ years, so maybe I am blind, but 20 cents doesn't make sense

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1